Bausch + Lomb Schedules Q1 2026 Earnings Release

  • Bausch + Lomb will release its first-quarter 2026 financial results on April 29, 2026.
  • A conference call and live webcast are scheduled for 8:00 AM ET on the same day.
  • Materials will be available on the Investor Relations section of the Bausch + Lomb website prior to the call.
  • The conference call dial-in numbers and webcast link are provided for North America and international participants.

The upcoming earnings release provides a crucial data point for assessing Bausch + Lomb’s performance as a standalone entity. The company operates within a large and fragmented global eye health market, facing both organic growth opportunities and competitive pressures. Investor focus will be on the sustainability of recent growth and the execution of its strategic initiatives.

Market Trends
The company's performance will reflect ongoing shifts in consumer preferences towards vision correction and the impact of telehealth on eye care services.
Competitive Landscape
The results will reveal how Bausch + Lomb is navigating increased competition from both established players and emerging direct-to-consumer brands in the eye health market.
Integration Risk
The company's ability to achieve synergies and operational efficiencies following its separation from Bausch Health will be a key indicator of long-term value creation.